Research Progress of CDK4/6 Inhibitors in Non-small Cell Lung Cancer
Lung cancer is the leading cause of cancer-related death worldwide. Non-small cell lung cancer (NSCLC) accounts for 80%-85% of lung cancer. Malignant tumors can proliferate indefinitely, and cell cycle regulation is abnormal which is one of the characteristics of malignant tumor. Cyclin D-dependent...
Shranjeno v:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Chinês |
| Izdano: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2020-03-01
|
| Serija: | Chinese Journal of Lung Cancer |
| Teme: | |
| Online dostop: | http://dx.doi.org/10.3779/j.issn.1009-3419.2020.03.07 |
| Oznake: |
Brez oznak, prvi označite!
|